Adaptimmune Therapeutics PLC financial data

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Adaptimmune Ltd (to 3/17/2015)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 313 % -7.84%
Debt-to-equity 391 % +69.9%
Return On Assets -15.1 % +50.2%
Operating Margin -25.8 % +84.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.54B shares +12.7%
Common Stock, Shares, Outstanding 1.53B shares +12.7%
Entity Public Float 191M USD -21.7%
Common Stock, Value, Issued 2.08M USD +11.9%
Weighted Average Number of Shares Outstanding, Basic 1.53B shares +13%
Weighted Average Number of Shares Outstanding, Diluted 1.53B shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40.9M USD +459%
Revenue from Contract with Customer, Excluding Assessed Tax 175M USD +146%
Research and Development Expense 143M USD +23%
General and Administrative Expense 71.9M USD -0.89%
Costs and Expenses 220M USD +17%
Operating Income (Loss) -45.1M USD +61.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43.3M USD +53.1%
Income Tax Expense (Benefit) 1.23M USD -58.9%
Net Income (Loss) Attributable to Parent -44.5M USD +53.2%
Earnings Per Share, Basic -0.03 USD/shares +62.5%
Earnings Per Share, Diluted -0.04 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117M USD +29.6%
Accounts Receivable, after Allowance for Credit Loss, Current 12.5M USD +1484%
Inventory, Net 1.87M USD
Other Assets, Current 3.38M USD +101%
Assets, Current 244M USD +11.3%
Property, Plant and Equipment, Net 44.8M USD -14.8%
Operating Lease, Right-of-Use Asset 20.5M USD -3.79%
Intangible Assets, Net (Excluding Goodwill) 4.28M USD +1015%
Other Assets, Noncurrent 968K USD
Assets 317M USD +7.01%
Accounts Payable, Current 9.07M USD -34.9%
Employee-related Liabilities, Current 11.3M USD +2.07%
Accrued Liabilities, Current 31.5M USD +17.4%
Contract with Customer, Liability, Current 18.7M USD -36.2%
Liabilities, Current 63.5M USD -15.6%
Contract with Customer, Liability, Noncurrent 147M USD +23.6%
Operating Lease, Liability, Noncurrent 20.5M USD -0.32%
Other Liabilities, Noncurrent 4.94M USD +264%
Liabilities 237M USD +13.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.14M USD -5135%
Retained Earnings (Accumulated Deficit) -1.02B USD -4.57%
Stockholders' Equity Attributable to Parent 80M USD -9.24%
Liabilities and Equity 317M USD +7.01%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32M USD +14.3%
Net Cash Provided by (Used in) Financing Activities 29.2M USD +14816%
Net Cash Provided by (Used in) Investing Activities -358K USD -101%
Common Stock, Shares Authorized 2.04B shares +19.8%
Common Stock, Shares, Issued 1.53B shares +12.7%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49M USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119M USD +28.3%
Deferred Tax Assets, Valuation Allowance 295M USD +83.7%
Deferred Tax Assets, Gross 302M USD +82.2%
Operating Lease, Liability 24.6M USD -3.79%
Depreciation 2.77M USD +67%
Payments to Acquire Property, Plant, and Equipment 102K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -49.8M USD +51.1%
Lessee, Operating Lease, Liability, to be Paid 32.9M USD +5.81%
Property, Plant and Equipment, Gross 97M USD +5.28%
Operating Lease, Liability, Current 4.18M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD -16.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD -2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +23.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.29M USD +50.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.5M USD -17.2%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.34M USD +1.88%
Additional Paid in Capital 1.1B USD +3.9%
Amortization of Intangible Assets 4.21M USD
Deferred Tax Assets, Net of Valuation Allowance 7.1M USD +34.8%
Share-based Payment Arrangement, Expense 12.3M USD -2.78%